ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013